Introduction
Magnesium is an important intracellular cation. Magnesium is an important intracellular cation. There is increasing evidence that Magnesium plays a crucial role in in preventing and terminating cardiac arrhythmias1 .The physiological role of Magnesium is to assist regulation of conventional cardiac rhythm 2, 3 . Arrhythmias are not uncommon after Coronary Artery Bypass Graft Surgery (CABG) 4 . The etiology of arrhythmias after CABG is multifactorial 5 . The factors are advanced age, male sex, hypertension, hypothyroidism, withdrawal of ß-blockers, impaired cardiac function, chronic lung disease, chronic renal failure, diabetes, cardiopulmonary bypass and cardioplegia, myocardial ischemia and reperfusion, myocardial infarction, right coronary artery disease, local inflammatory reaction, metabolic disorder, excessive catecholamine and electrolyte imbalance particularly hypomagnesaemia which has also been identified as an independent predictor of postoperative Atrial Fibrillation (AF)5. Several studies have shown that 50% or more of patients with AF, 40%-47% supraventricular arrhythmia and 34% ventricular arrhythmias suffer from hypomagnesaemia 6,7,8 .
There are reports suggested that Magnesium reduces the incidence of ventricular arrhythmia and supraventricular arrhythmias including AF by prolonging the atrial and atrioventricular nodal refractory period 1, 6 .These different forms of arrhythmias have the same clinical implications in early recovery phase of patients after cardiac surgery 9, 10 .
Potential complications of postoperative arrhythmia include thromboembolic events, haemodynamic compromise and increase length of stay and cost of hospitalisation 10,11,12 .
Hypomagnesaemia has been observed after cardiac surgery. Administration of Magnesium offers special potential benefit to a patient undergoing conventional CABG 4 . Advantages of Magnesium include easy availability, less cost, decreased incidence and duration of AF and Ventricular Tachycardia (VT), improved cardiac index, and reduction in infarct size 4 . In human and animals models, reperfusion injury due to the release of cross clamp can be attenuated by Magnesium administration resulting in better systolic indices of contractility and reduction of mortality. The present study was designed to evaluate the effectiveness of peroperative use of intravenous magnesium in reducing the incidence of per and postoperative arrhythmias in patients undergoing conventional CABG surgery.
Materials and Methods
In this prospective comparative study a total sixty patients of both sexes and different ages (thirty patients in All patients underwent CABG with blood cardioplegia for myocardial protection after cross clamping. Postoperatively patients were ventilated with Synchronized Intermittent Mandatory Ventilation (SIMV) and pressure support, till extubation. Serum Magnesium levels were monitored preoperatively, on shifting to Cardiac Intensive Care Unit (CICU), and later at 6 hours, 12 hours, and 24 hours postoperatively. ECG monitoring was continued peroperative and postoperative period for 24 hours and analyzed for SVT, AF, atrial flutter, non-sustained VT, and bradycardia.
Use of defibrillator and pacemaker were also noted. Peroperative complications were immediately detected and treated as per cause. Parameters recorded per and post operatively wereaortic cross clamp time, Cardio-Pulmonary Bypass (CPB) time, total surgery time, HR, SBP, DBP, and arrhythmias. Parameters were recorded at 5 minutes interval per-operatively and hourly for 24 hours during postoperative period.
All collected data were analyzed by using Statistical Package for Social Sciences (SPSS) for windows version 17.0. All results were expressed as mean ± Standard Deviation (SD) or in frequencies (percentage) as applicable. The results were compared using Student's 't' test. Results are considered statistically significant if p <0.05.
There are several limitations in our study. We could not find the previous history of arrhythmias and the relation of preoperative antiarrhythmic drug therapy with post-operative arrhythmias.
Results
Patients' characteristics are shown in Table- I. There were no significant (p>0.05) differences regarding age, weight, sex, preoperative LVEF, preoperative anti-arrhythmic medications, duration of myocardial infarction, New York Heart Association (NYHA) classification and cross clamp time among both the groups. Total operation time and CPB time were significantly (p<0.05) more in Group-II than that of Group-I. This extra time was required to stabilize the various forms of arrhythmias during weaning from CPB.
Preoperative baseline Magnesium levels were comparable in both groups. There were significantly (p < 0.05) low Magnesium levels in Group-II patients than that of Group-I at CICU arrival and after 6, 12, and 24 hours (Table-I). After release of cross clamp, eleven patients (36.67%) of Group-II and four patients (13.33%) of Group-I required defibrillation, whereas six patients (20%) of Group-II and two patients (6.67%) of Group-I required cardioversion (Table-I) .
Values of Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) mesured at different timing (before induction, before starting CPB, after starting CPB and after arrival in CICU) are shown in table-II, III and IV respectively. In group II patients, the fluctuations of HR, SBP and DBP were significantly more than that of group I patients. But before induction HR, SBP and DBP were comparable in two groups (Figures 1, 2 & 3) . The incidence of intra-operative arrhythmias in operation theatre (OT) ( Table V) and post-operative arrhythmias (within 24 hours) in cardiac intensive care unit (Table VI) were variable in both the groups. In group I, these incidences of arrhythmias were significantly less than that of group II. But intraoperative ventricular tachycardia and postoperative bradycardia were comparable in both groups. Nine patients (30%) after cross clamp release and 15 patients (50%) after finishing CPB among group I, whereas 1 patient (3.33%) after cross clamp release and 5 patients (16.67%) after finishing CPB among group II had no arrhythmias during intraoperative period at operation theatre (Table V) . A good number of patients in group II developed multiple arrhythmias both in OT and CICU. These multiple arrhythmias were significantly less (p value < 0.05) in group I patients both in OT and CICU (Table-V and Table-VI) . Twenty patients (66.67%) in group I developed no arrhythmia in postoperative period, in comparison to 11 patients (36.67%) in group II (Table-VI) . Values are presented as number (percentage). Analysis was done by Student's 't' test. NS: Not Significance p>0.05 (among two groups). Sig: Significant p<0.05 (among two groups). Supra Ventricular Tachycardia (SVT) , Atrial Fibrillation (AF), Ventricular Tachycardia (VT), Ventricular Premature Contraction (VPC), Cardio Pulmonary Bypass (CPB).
Fig-1: Graphical relation of heart rate at different time intervals between group I & II

Discussion
Magnesium plays an important role in cardiovascular physiology 13 . The physiological role of Magnesium is to assist regulation of conventional cardiac rhythm 2 . Hypomagnesaemia is commonly observed after cardiac surgery which may be related to haemodilution, intra-operative and postoperative cellular depletion, intra-operative diuretics use, secondary hyperaldosteronism, high level of epinephrine, increased anabolic activity, extreme stress and increased urinary loss 14 . In this study, mean Magnesium was reduced at CICU in Group-II and those patients were more vulnerable to develop various types of per and postoperative arrhythmias but it took 24 hours' time to normalize the Magnesium value. Although, a number of studies reveal that this normalization of Magnesium level takes more than 48 hours after arrival to CICU 12,13,15 .
Regarding haemodynamic status, in this study Magnesium treated group have shown better stability than that of non-magnesium group both peroperatively in OT and postoperatively in CICU. Heart rate, SBP and DBP fluctuations were more in non-magnesium group and these phenomenon's were predicted by a large number of authors 12, 16 .
The incidence of AF after CABG surgery remains relatively high. Lower serum Magnesium levels have been found to be associated with an increased incidence of AF 16,17, 18 . In this study, after releasing of cross clamp and after finishing of CPB, incidence of AF was higher in low Magnesium group. Nevertheless, it had also been found that not only AF, incidence of other supraventricular and ventricular arrhythmias were also higher in low magnesium group. These different forms of arrhythmias might have been resulted from episodes of myocardial ischaemia probably due to possible kinking of grafts or poor myocardial protection or rapid re-warming after cross clamp remova l4,19,20 . Low Magnesium is associated with the development of postoperative ventricular arrhythmia. For this reason, perioperative Magnesium supplementation has been suggested to play a role in the prophylaxis of arrhythmia after CABG surgery 12,21, 22 . When Magnesium levels are corrected by the administration of Magnesium peroperatively, medical complications are significantly reduced. In our study, we used single dose of Magnesium infusion just after induction, as a result developed significantly (p<0.05) lower number of different types of arrhythmias in OT as well as CICU within first 24 hours period. The incidence of different arrhythmias can also be minimized by continuing the Magnesium infusion in CICU as described by many authors 13,15,21, 23 . Values are presented as number (percentage). Analysis was done by Student's 't' test. N S: Not significance p>0.05 (among two groups). Sig: Significant p<0.05 (among two groups). Supra Ventricular Tachycardia (SVT), Atrial Fibrillation (AF), Ventricular Tachycardia (VT), Ventricular Premature Contraction (VPC).
Table-VI: Post-operative arrhythmias (after 24 hours) at CICU in two groups (n=60)
In this study, patients who developed arrhythmias were treated with antiarrhythmics medications as appropriate. We did not find any correlation between antiarrhythmics medications and Magnesium infusion. Cagli et al 24 evaluated that postoperative administration of intravenous low dose Amiodarone and Magnesium sulfate combination would reduce the incidence of AF following CABG surgery.
Conclusion
Low Magnesium levels are a frequent finding after conventional CABG surgery. This acute loss of Magnesium has been regarded as an etiology of many per and post operative arrhythmias. Magnesium decreases after load, provides coronary vasodilatation, decreases platelet aggregation and protect cell against ischaemia and reperfusion. This study revealed that peroperative administration of Magnesium provided a significant reduction in arrhythmias per and postoperatively. Though, we have studied with single dose of Magnesium infusion just after induction of anaesthesia, but still there is scope to investigate different doses of Magnesium infusion at various timing in large population with variable demographic features for better outcome to minimize the incidence of multiple arrhythmias during off or on pump CABG surgery.
